Athira Pharma Inc (ATHA) financials · $26.6M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Athira Pharma Inc (ATHA) $26.6M cap.
| Line | FY2024 | FY2023 |
|---|---|---|
| Net Income | -$96.9M | -$117.7M |
| EPS (Diluted) | -$2.52 | -$3.09 |
| Line | FY2024 | FY2023 |
|---|---|---|
| Total Assets | $58.8M | $160.2M |
| Cash & Equivalents | $48.4M | $90.6M |
| Total Liabilities | $13.9M | $30.1M |
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Cash Flow | -$97.2M | -$100.8M |
| Investing Cash Flow | $54.8M | $95.1M |
| Financing Cash Flow | $194.0K | $493.0K |
FAQ
What is ATHA P/E and revenue?
Athira Pharma Inc (ATHA) $26.6M cap.
What is ATHA revenue?
ATHA income-statement cache has no revenue figure yet.
Is ATHA profitable?
Athira Pharma Inc last cached net income is -$96.9M (FY2024).
What are ATHA total assets?
Athira Pharma Inc last cached total assets are $58.8M (FY2024).
What is ATHA free cash flow?
No cached cash-flow row for ATHA yet.
Not investment advice. Cached statements, not a live tape.